Navigation Links
Moderate Aerobics May Ease Insomnia Symptoms
Date:6/12/2008

Brazilian study finds 36% reduction in time awake and a drop in anxiety levels

THURSDAY, June 12 (HealthDay News) -- A session of moderate aerobic exercise can help reduce anxiety and improve the quality of sleep for insomnia patients, according to a Brazilian study. Heavy aerobic or moderate strength exercises don't have the same effect.

Researchers at the Federal University of Sao Paulo divided 28 women and eight men with primary chronic insomnia into three exercise groups -- moderate aerobic, heavy aerobic, and moderate strength -- and one control group.

After the exercise session, those who did moderate aerobic exercise showed reductions in sleep onset latency (54 percent) and wake time (36 percent) and increases in total sleep time (21 percent) and sleep efficiency (18 percent). They also showed a 7 percent decrease in anxiety.

"These findings indicate that there is a way to diminish the symptoms of insomnia without using medication," study author Giselle S. Passos said in a prepared statement.

"This is the first study to look at the importance of using physical exercise to treat insomnia and may contribute to increased quality of life in people with one of the most important kind of sleep disorders around the world," Passos said.

The findings were presented Wednesday at the annual meeting of the Associated Professional Sleep Societies, in Baltimore.

More information

The American Academy of Family Physicians has more about insomnia.



-- Robert Preidt



SOURCE: American Academy of Sleep Medicine, news release, June 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
2. Moderate Exercise Cuts Risk of Metabolic Syndrome
3. Gene variant linked to moderated symptoms of beta-thalassemia
4. Moderate Aerobic Fitness Levels May Cut Stroke Risk
5. A Drug With Efficacy Superior to That of Memantine Would Earn up to a 50% Patient Share in the Moderate-to-Severe Alzheimers Disease Drug Market
6. Moderate alcohol consumption in middle age can lower cardiac risk
7. Ad in USA TODAY Touts Benefits of Moderate UV Exposure
8. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
9. Drug Works Well for Moderate-to-Severe Psoriasis
10. IF You Had Survived a Brutal Rape at Gunpoint, Would You Teach Aerobics to Convicted Felons?
11. Aerobics Celebrates 40th Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... Tennessee (PRWEB) , ... February 13, 2016 , ... ... the Infusion Nurses Society (INS) states that vein visualization technology should be used ... by healthcare facilities around the world, the INS Standards mandate the use of ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a ... Providers list for its expertise in eClinical Solutions. DDi has built its solution ... technology needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory ...
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare Center for ... General Hospital on April 5-7. The series is a multi-day, multi-workshop event designed ... workshops cover a broad range of topics, including coaching skills, the scientific method ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , 12 februari 2016 ... een toonaangevende leverancier van productie en ontwikkeling ... industrieën, kondigt vandaag een uitbreiding aan van ... haar locatie in Charleston, SC ... geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... Maharashtra, February 12, 2016 ... report titled Chronic Inflammation Global Clinical Trials Review, ... of the global clinical trials landscape along with ... by Region, Country (G7 & E7), Trial Status, ... and reviews top companies involved and enlists all ...
Breaking Medicine Technology: